Which of the Following Is Considered a Benefit to the Clinical

question 3

Multiple Choice

Which of the following is considered a benefit to the clinical laboratory with point-of-care testing?

• A)less trauma for the patient
• B)financial savings
• C)decreased preanalytical errors such as incorrect patient ID and delay in transportation
• D)improved convenience

---

Definitions:

DES

Diethylstilbestrol, a synthetic estrogen once prescribed to prevent miscarriages and pregnancy complications, later linked to cancer and other reproductive issues.

Teratogens

Agents, such as chemicals or viruses, that can cause developmental malformations or defects in an embryo or fetus.

Obstetrician

A medical doctor specializing in the care of women during pregnancy, childbirth, and the postpartum period.

Pre-Eclampsia

A disorder in pregnancy characterized by high blood pressure and often a significant amount of protein in the urine, posing risks to both the mother and fetus.